Elissa Fuller Datz

Elissa Fuller Datz has a diverse work experience spanning over various industries and roles. Their most recent position was as the Senior Vice President of Global Strategic Alliances & Business Development at Novavax, starting in August 2023. Prior to that, they worked as the Chief Business Officer & General Counsel at Reset Pharmaceuticals from January 2023 to August 2023.

From 2012 to 2022, Elissa served at Otsuka Pharmaceutical Companies (U.S.), where they held multiple roles such as Executive Director, Head of Commercial Strategy and Head of Commercial Strategy. Their responsibilities included optimizing portfolios, sourcing partners, negotiating collaboration agreements, and leading global alliances in multinational business sectors like psychiatry, neuroscience, nephrology, and digital health.

Before Otsuka, Elissa held positions at Pierrel Research USA, Inc. as the Chief Executive Officer and as General Counsel. Elissa provided legal counsel, managed compliance matters, and handled regulatory support for clinical development programs and the importation and marketing of pharmaceutical products.

Additionally, Elissa worked as an Associate Attorney at Astor Weiss Kaplan & Mandel, LLP from 2006 to 2008. Their earliest known work experience was as a Regional GOTV Director for Obama for America in 2008.

Elissa Fuller Datz earned a J.D. degree in Law from Rutgers Law School in 2006. Prior to that, they obtained a B.A. degree in Music from American University.